Early PARacetamol (EPAR) trial: a study protocol for a randomised controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants

Documenti analoghi

• Use of intravenous paracetamol for patent ductus arteriosus closure in preterm and very low birth infants
  di: Thillathunisa Abdulkather
  Pubblicazione: (2018-10-01)
• Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates – A randomized controlled trial
  di: Meena, Vasudha, et al.
  Pubblicazione: (2020)
• Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates
  di: Terrin, Gianluca, et al.
  Pubblicazione: (2014)
• Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis
  di: Xiao, Yingqi, et al.
  Pubblicazione: (2020)
• Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trial
  di: Kumar, Ashutosh, et al.
  Pubblicazione: (2017)